Published in:
01-07-2020 | Coronavirus | Editorial
Imaging changes in patients with 2019-nCov
Authors:
Yueying Pan, Hanxiong Guan
Published in:
European Radiology
|
Issue 7/2020
Login to get access
Excerpt
In the past month, the outbreak of a new coronavirus from Wuhan, i.e., 2019-nCov, has spread rapidly across China and beyond, with an epidemiological link to the Huanan Seafood Wholesale Market, which sells live animals. The number of people diagnosed with the virus has shown a sharp rise. On January 30, 2020, China reported a total of 7,736 confirmed cases, 170 deaths, 9,267 suspected cases, and 124 discharged patients. Chinese health authorities did an immediate investigation to characterize and control the disease, including isolation of people suspected to have the disease, close monitoring of contacts, epidemiological and clinical data collection from patients, and development of diagnostic and treatment procedures. By January 7, 2020, Chinese scientists had isolated a novel coronavirus (nCoV) from patients in Wuhan. The genetic sequence of the 2019 novel coronavirus (2019-nCoV) enabled the rapid development of point-of-care real-time RT-PCR diagnostic tests specific for 2019-nCoV [
1]. The 2019-nCoV is a β CoV of group 2B with at least 70% similarity in genetic sequence to SARS-CoV [
2]. …